Commentary: Randomized Controlled Trials of Olanzapine Treatment of Borderline Personality Disorder: Two Similar Studies With Different Results
J Clin Psychiatry 2011;72(10):1363-1365
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
The author presents a comparison of 2 large concurrently conducted, industry-sponsored, randomized, placebo-controlled pharmacotherapy trials using essentially the same protocols and outcome measures and differing primarily on fixed-dose versus flexible-dose olanzapine administration for treatment. Since the published reports of these 2 trials are 2+ years apart, with 1 included in the same issue as this commentary, it is important to bring together the results of these trials.